Akums Drugs partners with Caregen to launch specialty nutraceuticals

This strategic alliance marks a significant step in introducing speciality nutraceuticals, Pharmaceuticals

Akums Drugs & Pharmaceuticals Ltd., India’s largest contract development and manufacturing organization (CDMO), has entered into an in-licensing agreement with Caregen Co., Ltd., a global biotechnology leader based in South Korea. This strategic alliance marks a significant step in introducing speciality nutraceuticals, Pharmaceuticals, differentiated topical and injectable cosmeceuticals—including advanced Skinceuticals and Hairceuticals—tailored to meet the unique needs of Indian consumers. 

The collaboration brings together Caregen’s global expertise in peptides, growth factors, and advanced formulations with Akums’ manufacturing capabilities and expansive market reach. By uniting their strengths, the partnership aims to deliver science-backed, innovative solutions aligned with the rising consumer focus on health, beauty, and wellness in India. 

The agreement sets the stage for the launch of an array of innovative products, including topical solutions for skin and hair care, injectable products targeting deeper rejuvenation and repair, and premium nutraceuticals designed for holistic wellness. These offerings leverage Caregen’s proprietary peptide-based technologies and Akums’ ability to scale production and ensure quality, enabling the introduction of global-standard products to Indian markets. 

India’s cosmeceutical and nutraceutical sectors are experiencing rapid growth, driven by increasing consumer awareness of health and wellness. This partnership positions Akums and Caregen as leaders in addressing the evolving needs of these markets. The products will cater to India’s diverse demographics, unique climatic conditions, and varied lifestyles, delivering customised solutions that resonate with local consumers.